Judy Lin

Judy Lin practices at Baylor Scott & White All Saints Medical Center - Fort Worth in Fort Worth, Texas, part of Baylor Scott & White Health.

Judy Lin's NPI, 1467771204, was assigned on May 19, 2010. Judy Lin holds District of Columbia license MD041246.

Judy Lin's primary practice is Baylor Scott & White All Saints Medical Center - Fort Worth, at 1400 Eighth Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 926-2544.

Judy Lin's primary practice is Baylor Scott & White All Saints Medical Center - Fort Worth in Fort Worth, Texas, part of Baylor Scott & White Health. Judy Lin is also affiliated with Saint Francis Hospital. The medical group on file is Baylor Scott & White Health. Dmand AI also links Judy Lin to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Judy Lin practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Judy Lin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Judy Lin's licenses on file in 2 states: District of Columbia and Maryland.

CMS data shows 327 Medicare services from Judy Lin across 4 procedure codes in 2024, for 200 Medicare patients. Medicare paid $31,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 200 Medicare patients who saw Judy Lin in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 3.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Judy Lin's median patient age at 48, with 66% women.

In 2024, Judy Lin wrote 129 Medicare Part D claims for 80 patients. 91% of them were for generic drugs. CMS names the drug for 51 of them, across 3 drugs with 11 or more claims each, at $539 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Judy Lin for performance year 2024, reported as part of a group. Judy Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Judy Lin from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 53% of the total. Pacira Pharmaceuticals Incorporated paid the most, $4,668.